@article{cab17d816b0e4cbdaacd54832b456a84,
title = "Signals transduced by Ca2+/calcineurin and NFATc3/c4 pattern the developing vasculature",
abstract = "Vascular development requires an orderly exchange of signals between growing vessels and their supporting tissues, but little is known of the intracellular signaling pathways underlying this communication. We find that mice with disruptions of both NFATc4 and the related NFATc3 genes die around E11 with generalized defects in vessel assembly as well as excessive and disorganized growth of vessels into the neural tube and somites. Since calcineurin is thought to control nuclear localization of NFATc proteins, we introduced a mutation into the calcineurin B gene that prevents phosphatase activation by Ca2+ signals. These CnB mutant mice exhibit vascular developmental abnormalities similar to the NFATc3/c4 null mice. We show that calcineurin function is transiently required between E7.5 and E8.5. Hence, early calcineurin/NFAT signaling initiates the later cross-talk between vessels and surrounding tissues that pattern the vasculature.",
author = "Graef, {Isabella A.} and Feng Chen and Lei Chen and Ann Kuo and Crabtree, {Gerald R.}",
note = "Funding Information: We would like to thank Fred Alt, Wasif Khan, Joel Neilson, Elizabeth Chao, Susan Palmieri, David Travers, and Irv Weissman for valuable advice and help; Phil Leder for providing the embryonic stem cells; Laurie Glimcher for providing the NFATc3 −/− mice; Phil Huie for performing the electron microscopy studies; Sebastian Gerety and David Anderson for kindly providing the ephrinB2 taulacZ mice and the ErbB3 in situ probe; Eric Olson for providing the MLC-2V in situ probe; Douglas Hanahan for providing the VEGF-A in situ probe; Elizabetta Dejana for the anti-VE-cadherin antibody; Tian Chi for help with the FACS analysis; and Tom Quertermous, Joe Weiss, Calvin Kuo, Hank Bayle, and Kryn Stankunas for helpful discussions and critical reading of the manuscript. This work was supported by a grant from the Howard Hughes Medical Institute and a grant from the NIH to G.R.C., a Capcure Foundation award (to I.A.G. and G.R.C.), and a career development award from the Leukemia and Lymphoma Society to F.C. ",
year = "2001",
month = jun,
day = "29",
doi = "10.1016/S0092-8674(01)00396-8",
language = "English",
volume = "105",
pages = "863--875",
journal = "Cell",
issn = "0092-8674",
number = "7",
}